Two Sigma Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.2M Sell
71,680
-628,708
-90% -$224M 0.02% 813
2025
Q4
$229M Buy
700,388
+623,963
+816% +$198M 0.32% 43
2025
Q3
$21.6M Buy
76,425
+73,182
+2,257% +$21.2M 0.03% 608
2025
Q2
$905K Sell
3,243
-356,273
-99% -$101M ﹤0.01% 2302
2025
Q1
$112M Sell
359,516
-542,770
-60% -$160M 0.24% 99
2024
Q4
$235M Buy
902,286
+543,545
+152% +$161M 0.51% 28
2024
Q3
$116M Sell
358,741
-183,407
-34% -$60M 0.25% 96
2024
Q2
$169M Buy
542,148
+429,765
+382% +$126M 0.39% 57
2024
Q1
$32M Buy
112,383
+15,142
+16% +$4.43M 0.08% 312
2023
Q4
$28M Sell
97,241
-618,747
-86% -$169M 0.06% 337
2023
Q3
$192M Sell
715,988
-270,913
-27% -$67.6M 0.52% 30
2023
Q2
$219M Buy
986,901
+41,426
+4% +$9.61M 0.55% 19
2023
Q1
$229M Buy
945,475
+17,524
+2% +$4.3M 0.65% 16
2022
Q4
$244M Sell
927,951
-2,284
-0.2% -$612K 0.77% 7
2022
Q3
$210M Buy
930,235
+126,402
+16% +$30.6M 0.71% 18
2022
Q2
$196M Sell
803,833
-241,382
-23% -$59.2M 0.65% 28
2022
Q1
$253M Buy
1,045,215
+52,923
+5% +$12.2M 0.75% 3
2021
Q4
$223M Sell
992,292
-72,653
-7% -$15.3M 0.48% 24
2021
Q3
$226M Buy
1,064,945
+125,064
+13% +$28.8M 0.51% 12
2021
Q2
$229M Buy
+939,881
New +$231M 0.52% 21
2021
Q1
Sell
-6,100
Closed -$1.46M 3777
2020
Q4
$1.4M Buy
+6,100
New +$1.41M ﹤0.01% 1750
2020
Q3
Sell
-325,550
Closed -$80.7M 3049
2020
Q2
$76.8M Buy
325,550
+182,669
+128% +$41.7M 0.38% 51
2020
Q1
$29M Buy
142,881
+114,548
+404% +$25M 0.24% 76
2019
Q4
$6.83M Sell
28,333
-65,483
-70% -$14.4M 0.02% 778
2019
Q3
$18.2M Sell
93,816
-593,662
-86% -$114M 0.06% 374
2019
Q2
$127M Buy
687,478
+30,676
+5% +$5.49M 0.42% 34
2019
Q1
$125M Buy
656,802
+570,716
+663% +$109M 0.4% 33
2018
Q4
$16.8M Sell
86,086
-194,584
-69% -$38M 0.07% 373
2018
Q3
$58.2M Sell
280,670
-307,799
-52% -$60.7M 0.16% 192
2018
Q2
$109M Buy
588,469
+383,825
+188% +$67.9M 0.32% 55
2018
Q1
$34.9M Sell
204,644
-366,739
-64% -$67.3M 0.12% 218
2017
Q4
$99.4M Buy
571,383
+79,938
+16% +$14.1M 0.32% 52
2017
Q3
$91.6M Sell
491,445
-109,286
-18% -$19.4M 0.32% 70
2017
Q2
$103M Buy
600,731
+228,078
+61% +$37.1M 0.37% 51
2017
Q1
$61.1M Sell
372,653
-125,351
-25% -$20.8M 0.21% 114
2016
Q4
$72.8M Buy
498,004
+443,531
+814% +$66.8M 0.28% 72
2016
Q3
$9.09M Sell
54,473
-564,872
-91% -$95.5M 0.03% 585
2016
Q2
$94.2M Sell
619,345
-28,213
-4% -$4.39M 0.4% 49
2016
Q1
$97.1M Buy
647,558
+446,275
+222% +$66.3M 0.46% 42
2015
Q4
$32.7M Sell
201,283
-611,999
-75% -$96.2M 0.16% 158
2015
Q3
$112M Sell
813,282
-241,626
-23% -$38.1M 0.58% 34
2015
Q2
$162M Buy
1,054,908
+508,757
+93% +$81.5M 0.76% 4
2015
Q1
$87.3M Buy
+546,151
New +$86M 0.41% 39
2014
Q4
Sell
-149,268
Closed -$21M 2203
2014
Q3
$21M Sell
149,268
-959,264
-87% -$125M 0.09% 281
2014
Q2
$131M Buy
+1,108,532
New +$128M 0.59% 17
2014
Q1
Sell
-317,965
Closed -$36.3M 1960
2013
Q4
$36.3M Buy
+317,965
New +$36.2M 0.2% 128

Other funds holding AMGN

Two Sigma Investments's AMGN Position: Q1 2026 in Review

Two Sigma Investments reduced its Amgen (AMGN) stake by 90% in Q1 2026, selling an estimated $224M and leaving 71,680 shares worth $25.2M. The position accounts for 0.02% of the portfolio, ranked #813.

Two Sigma Investments first reported a position in AMGN in Q4 2013 and has held it in 46 quarters since. The position peaked at $253M in Q1 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Two Sigma Investments held 71,680 shares of Amgen worth $25.2M as of Q1 2026.
  • Two Sigma Investments sold 628,708 Amgen shares in Q1 2026, an estimated $224M.
  • Amgen made up 0.02% of Two Sigma Investments's portfolio in Q1 2026, its #813 holding.
  • Two Sigma Investments first reported a position in Amgen in Q4 2013 and has held it in 46 quarters since.
  • Two Sigma Investments's Amgen position peaked at $253M in Q1 2022.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.